Sign in

CIK 0001652130 · Large accelerated filer

Intellia Therapeutics, Inc.

Sign in to watch
Ticker
NTLA
Exchange
Nasdaq
Industry
In Vitro & In Vivo Diagnostic Substances
FY end
Dec 31
Incorporated
DE
Entity type
operating
EIN
364785571
Phone
857-285-6200
Business address
400 TECHNOLOGY SQUARE, SUITE 100, CAMBRIDGE, MA
  1. 4 Option exercise EVP, Chief Financial Officer acquired 3,062 shares (option exercise)
  2. 144 Insider Sale of Securities
  3. 8-K Event Executive or director change
  4. S-3ASR Offering Registration Statement
  5. 10-Q Report Quarterly Report
  6. 8-K Event Results of operations
  7. 4 Planned sale Director sold 265 shares at $23.90 ($6,334)
  8. 8-K Event Regulation FD disclosure · Other events
  9. 8-K Event Regulation FD disclosure · Other events
  10. 8-K Event Regulation FD disclosure · Other events
  11. 10-Q Report Quarterly Report
  12. 8-K Event Results of operations
  13. 4 Planned sale Director sold 265 shares at $42.33 ($11,217)
  14. 144 Insider Sale of Securities
  15. 4 Planned sale Director sold 1,867 shares at $39.30 ($73,373)
  16. 144 Insider Sale of Securities
  17. 4 Open-market sale EVP, Chief Technical Officer sold 360 shares at $40.51 ($14,584)
  18. 4 Planned sale EVP, Chief Technical Officer sold 5,000 shares at $45.00 ($225,000)
  19. 144 Insider Sale of Securities
  20. 4 Grant or award Director acquired 1,673 shares (grant or award)

Page 11 of 37 · 725 filings